U.S. Wireless Telecom Stock News

In recent days, Boise Cascade has attracted fresh analyst attention as ongoing earnings outperformance, favorable value ratings, and active share repurchases have highlighted the business to investors. What stands out is how the company’s consistent earnings surprises, combined with perceptions of undervaluation, are reshaping sentiment toward this wood products and building materials distributor. We’ll now examine how this renewed earnings-focused optimism, especially around perceived...

Eli Lilly (LLY) has agreed to acquire psychedelic drug developer AtaiBeckley for up to US$3.8b, in a mental health focused deal that adds late stage depression therapies and expands the company’s neuroscience pipeline. See our latest analysis for Eli Lilly. Eli Lilly’s 27.19% 90 day share price return and 6.04% 1 month share price return suggest momentum has been building, while a 53.87% 1 year total shareholder return points to strong longer term performance as acquisitions and pipeline news...

Floor & Decor Holdings (FND) is drawing fresh attention after recent trading left the stock at US$56.79, with performance over the past month and past 3 months giving investors new reference points. See our latest analysis for Floor & Decor Holdings. Zooming out, Floor & Decor Holdings has seen its 30 day share price return of 13.4% contrast with a year to date share price decline of 9.8% and a 1 year total shareholder return decline of 27.8%. This points to recent momentum rebuilding after a...

The proposed US Senate bill targeting countries that buy Russian oil has put a fresh spotlight on US energy stocks, as investors weigh how new tariffs and trade frictions might reshape global supply routes and pricing power. This article looks at how that backdrop could influence a select group of US energy companies with larger market caps and relatively strong health scores, and why some may be better positioned than others if volatility in oil and gas markets increases. Below, you will...

Flex stock has delivered a very large 5 year gain, yet the current valuation checks suggest the shares still trade at a discount, with both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples pointing to undervaluation despite the recent pullback. Over the last 5 years, Flex has returned about 8.9x, which means recent weakness sits on top of a very strong long term share price performance. The expanded manufacturing partnership with Cerebras for AI accelerator...

Earlier this month, HEICO Corporation completed US$550.0 million of 4.950% Senior Notes due 2031 and US$650.0 million of 5.400% Senior Notes due 2036, using the proceeds to pay down borrowings under its US$2.20 billion revolving credit facility and preserve capacity for future acquisitions. The investment-grade ratings on both existing and newly issued notes underscore HEICO’s access to relatively efficient long-term financing, reinforcing management’s emphasis on balance sheet strength as a...

EastGroup Properties (EGP) has drawn fresh attention after its recent trading performance, with the stock last closing at $222.20. Investors are weighing that price against the company’s fundamentals and recent return profile. See our latest analysis for EastGroup Properties. Over the past year, EastGroup Properties has combined a 39.12% total shareholder return with strong recent momentum, including a 12.48% 1 month share price return and a 23.51% year to date share price return, which may...

CDW recently announced layoffs as part of organizational changes aimed at sharpening operating discipline and reallocating resources toward artificial intelligence–focused initiatives. The company plans to embed AI across its operations to boost efficiency and productivity, signaling a meaningful shift in how it delivers IT solutions for customers. Next, we’ll examine how CDW’s AI-driven restructuring and workforce reductions could influence its existing investment narrative and future...

ImmunityBio (IBRX) is back under the spotlight after investor optimism around its bladder cancer therapy Anktiva drove very large year to date share gains. Attention is now centered on regulatory and revenue timing questions. See our latest analysis for ImmunityBio. After a very large year to date share price return of 280.2%, ImmunityBio’s recent trading has cooled slightly, with a 7 day share price return decline of 6.6% and a 30 day share price return of 9.9%, keeping overall momentum...

City Holding stock is coming off a strong five year run, yet the valuation signals are split, with an intrinsic value estimate from the Excess Returns model pointing to upside while the market multiple view looks less forgiving. City Holding has returned 112.6% over the past 5 years, which puts more pressure on today’s valuation to be supported by future fundamentals. For a regional bank, the key support for the share price can come from consistent profitability and a resilient balance...

AvalonBay Communities recently reported that its second-quarter 2026 results followed a period of strong U.S. apartment demand, with same-store residential occupancy holding above 96%, even as elevated borrowing costs and interest expenses remained a drag. This combination of firm occupancy going into the peak leasing season and ongoing financing headwinds highlights the tension between operational strength and capital market pressures for the REIT. We’ll now examine how resilient occupancy...

Vericel stock has delivered a 32.0% return over the past year, yet its current valuation checks lean expensive, raising the question of how much of the story is already reflected in the share price. Over the last 1 year, Vericel has returned 32.0%. This puts recent shareholder gains front and center in any discussion of what the stock is worth today. For a company like Vericel, expectations around sustaining growth in its therapies can support the current pricing. However, any setback in...

Goosehead Insurance (GSHD) has drawn fresh attention after its recent share price move, with the stock up about 55% over the past month and about 24% over the past 3 months. See our latest analysis for Goosehead Insurance. Despite the recent 54.5% 1 month share price return and a 23.8% 3 month share price gain, Goosehead Insurance still shows weaker longer term performance. The 1 year total shareholder return is down 46.8% and the 5 year total shareholder return is down 54.4%, suggesting...

In recent days, analysts from Oppenheimer, Citi and UBS reiterated their views on Xylem, while updated models suggested the shares are now trading close to estimated fair value based on cash flow and earnings assumptions. The discussion has sharpened focus on Xylem’s post‑Evoqua shift toward higher‑margin, recurring revenue in water infrastructure, and how dependent that thesis is on the timing and reliability of government-funded projects. With Xylem’s transition toward recurring...

Iridium Communications stock has surged 162.8% year to date, yet its valuation checks send mixed signals, with an intrinsic value estimate based on a Discounted Cash Flow (DCF) model suggesting the shares trade at a large discount while market multiples point to a richer pricing. Year to date, Iridium Communications is up 162.8%, which puts extra focus on whether the current price still leaves room against any estimate of intrinsic value. The launch of the Iridium PNT ASIC chip and the...

New York has introduced a state-wide moratorium on new large, high-power data centers, highlighting constraints in available electricity for AI and cloud growth. The move places power generators and retail electricity providers such as Vistra (NYSE:VST) at the center of discussions about where future AI and tech infrastructure can be built. This policy shift draws fresh attention to long term power planning, grid reliability, and investment in capacity that could influence how companies like...

Recent commentary around Hershey (HSY) has centered on expectations for margin recovery as higher cost cocoa inventories roll off, set against cautious views on consumer demand, shipment timing, and limited progress in sales volume trends. See our latest analysis for Hershey. Despite the product news around REESE'S PIECES with Chocolate Cookie, recent attention on Hershey has been driven more by margin expectations and demand concerns. The stock has fallen around 11% on a 90 day share price...

United Natural Foods, Inc. recently announced a major leadership reshuffle, with current CFO Giorgio Matteo Tarditi becoming President and Chief Operating Officer and Alfredo Luchini, a longtime industrial and utilities finance executive, appointed as the new Chief Financial Officer effective August 10, 2026. This consolidation of sales, operations, technology, and finance under a refreshed senior team signals a concerted push to tighten execution, customer alignment, and operational...

Albertsons Companies stock has slipped over the past three years, even as some valuation checks now suggest the shares may be pricing in more caution than the current fundamentals alone would imply. Over the past three years, Albertsons Companies has delivered a total return that is down 25.4%. This puts recent price moves in the context of a longer period of weak shareholder outcomes. The push into AI-driven retail media through the Criteo integration can support margin and cash flow...

Hilltop Holdings (HTH) has drawn investor attention after recent trading left the stock at a last close of $38.68, with performance metrics over the past month and the past three months now under closer scrutiny. See our latest analysis for Hilltop Holdings. Looking beyond the latest move, Hilltop Holdings has a 30 day share price return of 3.70% and a year to date share price return of 14.10%, while the 1 year total shareholder return of 26.30% suggests recent momentum sits on top of a...

HealthEquity stock has returned 55.6% over the past three years, yet its valuation signals do not line up, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside while earnings-based multiples suggest the shares are on the expensive side. Over the past three years, HealthEquity has returned 55.6%, which puts more weight on whether today’s price can be backed by the company’s future cash flows rather than by recent share price momentum alone. Expectations for continued...

HBT Financial (HBT) stock has been drawing attention after recent market performance placed the regional bank in focus for investors looking at US community banking exposure and income focused financials. See our latest analysis for HBT Financial. Recent trading has been constructive for HBT Financial, with the share price gaining 9.78% over the past month and 27.46% year to date, while the 1 year total shareholder return of 33.87% and 5 year total shareholder return of 129.36% point to...

Coty (COTY) has drawn investor attention after agreeing to transition the Gucci Beauty license back to Kering for about $400 million, and has also seen its stock react to improving US consumer sentiment data. See our latest analysis for Coty. For context, Coty’s recent 1 month share price return of 37.37% and 7 day move of 16.52% mark a sharp rebound from a year to date share price decline of 16.08%. The 1 year total shareholder return is down 46.95% and the 3 year total shareholder return is...

Several upbeat analyst calls on Capital One Financial (COF) have put the stock back in focus, as investors weigh this wave of positive coverage against ongoing Discover integration work and expectations for softer near term earnings. See our latest analysis for Capital One Financial. At a share price of $208.03, Capital One Financial has recently swung between upbeat analyst sentiment and legal headlines. The stock has a 7 day share price return of 3.23% but a year to date share price decline...